GSK-J4
GSK J4 是一种细胞渗透性前药,可被巨噬细胞酯酶迅速水解为 GSK-J1,后者是一种强效的选择性 jumonji H3K27 去甲基化酶抑制剂;它能减弱脂多糖(LPS)诱导的原发性人类巨噬细胞中的促炎细胞因子产生(IC50 = 9 uM,用于抑制 TNFα 发布)。
Discription | GSK J4 is a cell permeable prodrug rapidly hydrolyzed by macrophage esterases to GSK-J1, a potent selective jumonji H3K27 demethylase inhibitor; attenuates lipopolysaccharide (LPS)-induced proinflammatory cytokine production in primary human macrophages (IC50 = 9 uM for the inhibition of TNF?? release). |
---|
目录号 | A12732 |
---|---|
分子式 | C24H27N5O2 |
分子量 | 417.5 |
CAS号 | 1373423-53-0 |
SMILES | CCOC(=O)CCNC1=NC(=NC(=C1)N2CCC3=CC=CC=C3CC2)C4=CC=CC=N4 |
其他名称 | GSK J4 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2